VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ALLO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ALLOAllogene Therapeutics, Inc.
$1.50$518M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALLOQuarterly Balance Sheet

Allogene Therapeutics, Inc. (ALLO) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Allogene Therapeutics, Inc. (ALLO) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

ALLO Balance Sheet

Quarterly statement

ALLO Balance Sheet

Allogene Therapeutics, Inc. (ALLO) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets340M273.29M257.75M260.72M282.65M291.58M303.39M304.42M457.12M395.36M459.12M473.45M502.1M481.46M528.82M569.06M513.03M469.74M471.32M502.86M
Cash & Short-Term Investments332.6M266.89M250.21M252.19M273.12M280.04M292.48M291.56M444.63M384.86M448.7M465.5M491.96M471.22M517.32M552.23M490.49M449.05M457.3M483.49M
Cash Only38.63M30.31M51.69M37.81M52.33M42.45M75.22M51.24M170.67M51.04M83.16M69.25M154.76M109.93M61.9M74.36M96.04M84.51M173.31M190.02M
Short-Term Investments293.98M236.58M198.52M214.38M220.79M237.59M217.26M240.32M273.96M333.82M365.54M396.26M337.2M361.29M455.42M477.87M394.45M364.54M283.99M293.46M
Accounts Receivable01.3M1.5M2.1M00002M1.7M01.6M00000000
Days Sales Outstanding---------7.03K-6.69K--------
Inventory00000000000-1.6M00000000
Days Inventory Outstanding--------------------
Other Current Assets05.11M6.04M6.42M9.54M11.53M10.91M12.85M10.5M010.42M7.95M10.14M10.24M11.5M00000
Total Non-Current Assets210.09M122.67M158.16M179.05M187.94M216.41M245.32M284.7M189.76M190.99M183.72M238.87M268.87M265.41M292.75M318.51M434.62M494.89M579.5M576.39M
Property, Plant & Equipment105.12M108.84M112.73M116.83M120.82M127.07M131.26M135.3M150.47M160.41M163.18M181.47M186.7M191.81M196.43M199.69M204.05M177.26M181.02M164.65M
Fixed Asset Turnover0.04x--------0.00x-0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments90.99M10.29M8.04M35.24M29.51M55.51M80.67M111.82M11.43M25.41M3.65M47.83M62.5M53.91M76.47M99.15M211.33M298.3M382.38M396.13M
Other Non-Current Assets13.98M3.53M37.39M26.98M37.6M33.83M33.39M37.58M27.87M5.16M16.9M9.58M19.67M19.68M19.86M19.67M19.23M19.33M16.11M15.61M
Total Assets550.09M395.96M415.9M439.77M470.59M507.98M548.71M589.12M646.88M586.35M642.84M712.33M770.97M746.87M821.58M887.57M947.64M964.63M1.05B1.08B
Asset Turnover0.01x--------0.00x-0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Asset Growth %16.89%-22.05%-24.2%-25.35%-27.25%-13.37%-14.64%-17.3%-16.1%-21.49%-21.76%-19.74%-18.64%-22.57%-21.82%-17.76%-15.89%-18.19%-14.42%-11.72%
Total Current Liabilities31.73M28.33M32.51M31.83M31.68M30.02M35.52M32.57M37.3M30.89M37.08M37.64M54.72M59.59M53.73M48.87M44.91M36.88M47.91M53.49M
Accounts Payable5.96M4.93M4.27M3.7M4.85M5.06M5.39M5.51M12.94M5.78M5.9M6.21M10.23M14.69M13.89M11.04M9.71M8.71M10.26M11.5M
Days Payables Outstanding-144.35119.9112.6211.23151.77155.0918.9716.91149.44-211.64--------
Short-Term Debt08.42M08.01M00007.22M6.93M06.58M00000000
Deferred Revenue (Current)00000000086K86K236K229K273K95K889K836K406K156K365K
Other Current Liabilities014.98M10.24M20.04M0012.15M0-7.22M-6.93M12.66M-6.58M0017.93M00016.13M0
Current Ratio10.72x9.65x7.93x8.19x8.92x9.71x8.54x9.35x12.25x12.80x12.38x12.58x9.18x8.08x9.84x11.64x11.42x12.74x9.84x9.40x
Quick Ratio10.72x9.65x7.93x8.19x8.92x9.71x8.54x9.35x12.25x12.80x12.38x12.62x9.18x8.08x9.84x11.64x11.42x12.74x9.84x9.40x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities82.19M88.75M90.85M92.61M94.36M92.57M91.01M92.8M94.54M94.09M93.53M91.59M93.34M95.02M100.97M98.74M100.79M72.53M77.72M55.81M
Long-Term Debt00000000000000000000
Capital Lease Obligations70.35M72.63M75.05M77.13M79.24M81.29M83.25M85.14M86.99M88.92M88.35M90.1M91.82M93.51M95.12M96.71M98.23M69.03M69.93M50.64M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities11.84M16.12M15.8M15.47M15.12M11.28M7.76M7.67M7.55M5.17M5.18M1.49M1.52M1.51M5.85M2.03M2.55M3.49M7.79M5.17M
Total Liabilities113.92M117.08M123.36M124.44M126.03M122.59M126.53M125.37M131.84M124.98M130.6M129.22M148.06M154.61M154.7M147.61M145.69M109.4M125.63M109.3M
Total Debt70.35M81.05M83.25M85.14M79.24M81.29M90.76M85.14M94.21M95.85M95.12M96.68M91.82M99.7M101.12M96.71M98.23M69.03M73.13M50.64M
Net Debt31.73M50.74M31.57M47.33M26.91M38.84M15.54M33.9M-76.46M44.81M11.97M27.43M-62.94M-10.23M39.22M22.35M2.19M-15.48M-100.19M-139.38M
Debt / Equity0.16x0.29x0.28x0.27x0.23x0.21x0.21x0.18x0.18x0.21x0.19x0.17x0.15x0.17x0.15x0.13x0.12x0.08x0.08x0.05x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-123.42x-141.02x-122.99x-119.35x-189.09x-397.22x-733.52x-661.93x------------
Total Equity436.18M278.88M292.54M315.33M344.56M385.39M422.18M463.75M515.04M461.37M512.23M583.1M622.91M592.26M666.88M739.96M801.95M855.23M925.2M969.94M
Equity Growth %26.59%-27.64%-30.71%-32%-33.1%-16.47%-17.58%-20.47%-17.32%-22.1%-23.19%-21.2%-22.33%-30.75%-27.92%-23.71%-21.67%-20.06%-14.3%-13.3%
Book Value per Share1.331.161.331.421.571.792.002.222.712.733.043.484.244.104.635.155.596.056.657.08
Total Shareholders' Equity436.18M278.88M292.54M315.33M344.56M385.39M422.18M463.75M515.04M461.37M512.23M583.1M622.91M592.26M666.88M739.96M801.95M855.23M925.2M969.94M
Common Stock345K245K229K223K220K219K212K210K209K170K169K168K167K146K144K144K144K143K142K142K
Retained Earnings-2.1B-2.05B-2.01B-1.97B-1.93B-1.88B-1.82B-1.76B-1.69B-1.63B-1.56B-1.47B-1.41B-1.33B-1.23B-1.14B-1.06B-983.2M-894.55M-828.48M
Treasury Stock00000000000000000000
Accumulated OCI-518K-183K269K235K-45K43K-89K157K-780K-927K-955K-2.41M-3.85M-5.93M-9.93M-12.96M-11.47M-9.25M-2.57M-398K
Minority Interest00000000000000000000